ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
The move marked a full exit from ANI, with the fund reporting no shares held as of September 30. These 10 stocks could mint the next wave of millionaires › On November 13, Oregon-based Stonepine Capital Management reported in its latest SEC filing that it fully exited its position in ANI Pharmaceuticals (NASDAQ:ANIP) , reflecting a $2.52 million net decrease. According to a regulatory filing with the Securities and Exchange Commission dated November 13, Stonepine Capital Management sold its entire position of 38,597 shares in ANI Pharmaceuticals (NASDAQ:ANIP) . The value of the transaction, based on average quarterly prices, was $2.52 million. Top holdings after the filing: NASDAQ:VSTM: $23.58 million (19.17% of AUM) NASDAQ:ADMA: $10.83 million (8.81% of AUM) NASDAQ:EOLS: $9.43 million (7.67% of AUM) NASDAQ:ZVRA: $7.70 million (6.26% of AUM) NASDAQ:NKTR: $4.84 million (3.93% of AUM) As of Friday, shares of ANI Pharmaceuticals were priced at $82.41, up 49% over the
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Assessing ANI Pharmaceuticals (ANIP) Valuation After a Strong Yearly Share Price Rally [Yahoo! Finance]Yahoo! Finance
- Is ANI Pharmaceuticals Stock Price Justified After 47% 2025 Rally? [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock.MarketBeat
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/19/25 - Form 4
- 12/12/25 - Form 4
- 12/9/25 - Form 4
- ANIP's page on the SEC website